Results 81 to 90 of about 3,808 (163)

Ethical Guidance for Investigational Implantable Neural Device Studies: Recommendations for Researchers and Research Ethics Committees. [PDF]

Neuromodulation
van Stuijvenberg OC, Bassil KC, de Vos CC, Geleijnse G, Noordmans HJ, Broekman MLD, van der Graaf R, Bertens RM, Lázaro-Muñoz G, Jongsma KR.   +9 more
europepmc   +1 more source

When genomics companies act as biobanks: governance challenges in an era of genomic assetization. [PDF]

Front Genet
Walker A.
europepmc   +1 more source

Financial Outcomes Among Medicaid Expansion Enrollees.

JAMA Netw Open
Becker NV, Levy H, Hirth RA, Clark SJ, Tipirneni R, Ayanian JZ.   +5 more
europepmc   +1 more source

Personalized risk prediction of financial toxicity in patients with cancer: an interpretable machine learning study. [PDF]

JNCI Cancer Spectr
Damgacioglu H, Sonawane K, Silvestri GA, Sterba KR, Hill EG, Cantor SB, Graboyes EM, Deshmukh AA.   +7 more
europepmc   +1 more source

The high price of innovation: addressing financial toxicity and healthcare inequity in gynecological malignancies. [PDF]

Front Oncol
Ghalleb M, Rahmouni E, Chabchoub A, Zaraa S, Zenzeri Y, Slimane M, Charfi L, Naija L, Ben Dhieb T.   +8 more
europepmc   +1 more source

Requirements for set-off in Japanese law. [PDF]

F1000Res
Okamoto H.
europepmc   +1 more source

Debt, Bankruptcy, and Credit Scores After Cancer Diagnosis.

JAMA Oncol
Uppal N, Gomez-Mayorga JL, O'Donoghue AL, Fleishman A, Bogdanovski AK, Roth EM, Broekhuis JM, Hu-Bianco QL, Esselen KM, James BC.   +9 more
europepmc   +1 more source

Bioethical challenges in the implementation of targeted anti-tumor therapies in low-resource settings: a perspective from Latin America. [PDF]

Explor Target Antitumor Ther
Chaux A.
europepmc   +1 more source

The Subtle Crisis: Public Domain Genomes and the Ethics of Translational Infrastructure. [PDF]

Ethics Hum Res
LoTempio JE.
europepmc   +1 more source